1
|
Chen H, Guo S, Zhuang Z, Ouyang S, Lin P, Zheng Z, You Y, Zhou X, Li Y, Lu J, Liu N, Tao J, Long H, Zhao P. Intelligent Identification of Cerebrospinal Fluid for the Diagnosis of Parkinson's Disease. Anal Chem 2024; 96:2534-2542. [PMID: 38302490 DOI: 10.1021/acs.analchem.3c04849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2024]
Abstract
Cerebrospinal fluid (CSF) biomarkers are more sensitive than the Movement Disorder Society (MDS) criteria for detecting prodromal Parkinson's disease (PD). Early detection of PD provides the best chance for successful implementation of disease-modifying treatments, making it crucial to effectively identify CSF extracted from PD patients or normal individuals. In this study, an intelligent sensor array was built by using three metal-organic frameworks (MOFs) that exhibited varying catalytic kinetics after reacting with potential protein markers. Machine learning algorithms were used to process fingerprint response patterns, allowing for qualitative and quantitative assessment of the proteins. The results were robust and capable of discriminating between PD and non-PD patients via CSF detection. The k-nearest neighbor regression algorithm was used to predict MDS scores with a minimum mean square error of 38.88. The intelligent MOF sensor array is expected to promote the detection of CSF biomarkers due to its ability to identify multiple targets and could be used in conjunction with MDS criteria and other techniques to diagnose PD more sensitively and selectively.
Collapse
Affiliation(s)
- Huiting Chen
- School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
| | - Siyun Guo
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Zehong Zhuang
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Sixue Ouyang
- School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
| | - Peiru Lin
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Zhiyuan Zheng
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Yuanyuan You
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Xiang Zhou
- School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
| | - Yuan Li
- School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
| | - Jiajia Lu
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Ningxuan Liu
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Jia Tao
- School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
| | - Hao Long
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Peng Zhao
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
2
|
Chappard A, Leighton C, Saleeb RS, Jeacock K, Ball SR, Morris K, Kantelberg O, Lee J, Zacco E, Pastore A, Sunde M, Clarke DJ, Downey P, Kunath T, Horrocks MH. Single-Molecule Two-Color Coincidence Detection of Unlabeled alpha-Synuclein Aggregates. Angew Chem Int Ed Engl 2023; 62:e202216771. [PMID: 36762870 PMCID: PMC10946743 DOI: 10.1002/anie.202216771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 02/09/2023] [Accepted: 02/10/2023] [Indexed: 02/11/2023]
Abstract
Protein misfolding and aggregation into oligomeric and fibrillar structures is a common feature of many neurogenerative disorders. Single-molecule techniques have enabled characterization of these lowly abundant, highly heterogeneous protein aggregates, previously inaccessible using ensemble averaging techniques. However, they usually rely on the use of recombinantly-expressed labeled protein, or on the addition of amyloid stains that are not protein-specific. To circumvent these challenges, we have made use of a high affinity antibody labeled with orthogonal fluorophores combined with fast-flow microfluidics and single-molecule confocal microscopy to specifically detect α-synuclein, the protein associated with Parkinson's disease. We used this approach to determine the number and size of α-synuclein aggregates down to picomolar concentrations in biologically relevant samples.
Collapse
Affiliation(s)
- Alexandre Chappard
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Craig Leighton
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
- Centre for Regenerative MedicineInstitute for Stem Cell ResearchSchool of Biological SciencesThe University of EdinburghEdinburghEH16 4UUUK
| | - Rebecca S. Saleeb
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Kiani Jeacock
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Sarah R. Ball
- School of Medical SciencesFaculty of Medicine and Health, and Sydney NanoThe University of SydneySydneyNSW 2006Australia
| | - Katie Morris
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Owen Kantelberg
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Ji‐Eun Lee
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Elsa Zacco
- Centre for Human Technologies (CHT)Istituto Italiano di Tecnologia (IIT)Via Enrico Melen, 8316152GenovaItaly
| | - Annalisa Pastore
- European Synchrotron Radiation Facility71 Ave des Martyrs38000GrenobleFrance
| | - Margaret Sunde
- School of Medical SciencesFaculty of Medicine and Health, and Sydney NanoThe University of SydneySydneyNSW 2006Australia
| | - David J. Clarke
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | | | - Tilo Kunath
- Centre for Regenerative MedicineInstitute for Stem Cell ResearchSchool of Biological SciencesThe University of EdinburghEdinburghEH16 4UUUK
| | - Mathew H. Horrocks
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| |
Collapse
|
3
|
Chappard A, Leighton C, Saleeb RS, Jeacock K, Ball SR, Morris K, Kantelberg O, Lee J, Zacco E, Pastore A, Sunde M, Clarke DJ, Downey P, Kunath T, Horrocks MH. Single-Molecule Two-Color Coincidence Detection of Unlabeled alpha-Synuclein Aggregates. ANGEWANDTE CHEMIE (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2023; 135:e202216771. [PMID: 38516037 PMCID: PMC10952349 DOI: 10.1002/ange.202216771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Indexed: 02/12/2023]
Abstract
Protein misfolding and aggregation into oligomeric and fibrillar structures is a common feature of many neurogenerative disorders. Single-molecule techniques have enabled characterization of these lowly abundant, highly heterogeneous protein aggregates, previously inaccessible using ensemble averaging techniques. However, they usually rely on the use of recombinantly-expressed labeled protein, or on the addition of amyloid stains that are not protein-specific. To circumvent these challenges, we have made use of a high affinity antibody labeled with orthogonal fluorophores combined with fast-flow microfluidics and single-molecule confocal microscopy to specifically detect α-synuclein, the protein associated with Parkinson's disease. We used this approach to determine the number and size of α-synuclein aggregates down to picomolar concentrations in biologically relevant samples.
Collapse
Affiliation(s)
- Alexandre Chappard
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Craig Leighton
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
- Centre for Regenerative MedicineInstitute for Stem Cell ResearchSchool of Biological SciencesThe University of EdinburghEdinburghEH16 4UUUK
| | - Rebecca S. Saleeb
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Kiani Jeacock
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Sarah R. Ball
- School of Medical SciencesFaculty of Medicine and Health, and Sydney NanoThe University of SydneySydneyNSW 2006Australia
| | - Katie Morris
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Owen Kantelberg
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Ji‐Eun Lee
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | - Elsa Zacco
- Centre for Human Technologies (CHT)Istituto Italiano di Tecnologia (IIT)Via Enrico Melen, 8316152GenovaItaly
| | - Annalisa Pastore
- European Synchrotron Radiation Facility71 Ave des Martyrs38000GrenobleFrance
| | - Margaret Sunde
- School of Medical SciencesFaculty of Medicine and Health, and Sydney NanoThe University of SydneySydneyNSW 2006Australia
| | - David J. Clarke
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| | | | - Tilo Kunath
- Centre for Regenerative MedicineInstitute for Stem Cell ResearchSchool of Biological SciencesThe University of EdinburghEdinburghEH16 4UUUK
| | - Mathew H. Horrocks
- EaStCHEM School of ChemistryThe University of EdinburghEdinburghEH9 3FJUK
| |
Collapse
|
4
|
Leitão AD, Spencer B, Sarsoza F, Ngolab J, Amalraj J, Masliah E, Wu C, Rissman RA. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice. J Alzheimers Dis 2023; 95:349-361. [PMID: 37522208 PMCID: PMC10578232 DOI: 10.3233/jad-230232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2023] [Indexed: 08/01/2023]
Abstract
BACKGROUND Alzheimer's disease (AD) cases are often characterized by the pathological accumulation of α-synuclein (α-syn) in addition to amyloid-β (Aβ) and tau hallmarks. The role of α-syn has been extensively studied in synucleinopathy disorders, but less so in AD. Recent studies have shown that α-syn may also play a role in AD and its downregulation may be protective against the toxic effects of Aβ accumulation. OBJECTIVE We hypothesized that selectively knocking down α-syn via RNA interference improves the neuropathological and biochemical findings in AD mice. METHODS Here we used amyloid precursor protein transgenic (APP-Tg) mice to model AD and explore pathologic and behavioral phenotypes with knockdown of α-syn using RNA interference. We selectively reduced α-syn levels by stereotaxic bilateral injection of either LV-shRNA α-syn or LV-shRNA-luc (control) into the hippocampus of AD mice. RESULTS We found that downregulation of α-syn results in significant reduction in the number of Aβ plaques. In addition, mice treated with LV-shRNA α-syn had amelioration of abnormal microglial activation (Iba1) and astrocytosis (GFAP) phenotypes in AD mice. CONCLUSION Our data suggests a novel link between Aβ and α-syn pathology as well as a new therapeutic angle for targeting AD.
Collapse
Affiliation(s)
- André D.G. Leitão
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
| | - Brian Spencer
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
| | - Floyd Sarsoza
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
- VA San Diego Healthcare System, La Jolla, CA, USA
| | - Jennifer Ngolab
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
| | - Jessica Amalraj
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
| | | | - Chengbiao Wu
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
| | - Robert A. Rissman
- Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
- Department of Physiology and Neuroscience, Alzheimer’s Therapeutic Research Institute of the Keck School of Medicine of the University of Southern California, San Diego, CA, USA
- VA San Diego Healthcare System, La Jolla, CA, USA
| |
Collapse
|
5
|
Lau D, Magnan C, Hill K, Cooper A, Gambin Y, Sierecki E. Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay. ACS Chem Neurosci 2022; 13:883-896. [PMID: 35286811 PMCID: PMC8990999 DOI: 10.1021/acschemneuro.1c00553] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
The quantification of α-synuclein aggregates has emerged as a promising biomarker for synucleinopathies. Assays that amplify and detect such aggregates have revealed the presence of seeding-competent species in biosamples of patients diagnosed with Parkinson's disease. However, multiple species, such as oligomers and amyloid fibrils, are formed during the aggregation of α-synuclein; these species are likely to coexist in biological samples, and thus it remains unclear which species(s) are contributing to the signal detected in seeding assays. To identify individual contributions to the amplification process, recombinant oligomers and preformed fibrils were produced and purified to characterize their individual biochemical and seeding potential. Here, we used single molecule spectroscopy to track the formation and purification of oligomers and fibrils at the single particle level and compare their respective seeding potential in an amplification assay. Single molecule detection validates that size-exclusion chromatography efficiently separates oligomers from fibrils. Oligomers were found to be seeding-competent, but our results reveal that their seeding behavior is very different compared to that of preformed fibrils, in our amplification assay. Overall, our data suggest that even a low number of preformed fibrils present in biosamples is likely to dominate the response in seeding assays.
Collapse
Affiliation(s)
- Derrick Lau
- EMBL Australia Node for Single Molecule Sciences and School of Medical Sciences, Faculty of Medicine, the University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Chloé Magnan
- EMBL Australia Node for Single Molecule Sciences and School of Medical Sciences, Faculty of Medicine, the University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Kathryn Hill
- The Australian Parkinson’s Mission, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
| | - Antony Cooper
- The Australian Parkinson’s Mission, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
- St Vincent’s Clinical School, UNSW Sydney, Darlinghurst, New South Wales 2010, Australia
| | - Yann Gambin
- EMBL Australia Node for Single Molecule Sciences and School of Medical Sciences, Faculty of Medicine, the University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Emma Sierecki
- EMBL Australia Node for Single Molecule Sciences and School of Medical Sciences, Faculty of Medicine, the University of New South Wales, Sydney, New South Wales 2052, Australia
| |
Collapse
|